An investment of $1 billion to increase access to innovative antibiotics and high-quality treatment of antimicrobial resistance (AMR), could boost the European Union’s (EU) economy by $88 billion a year, by the year 2050.
Logical Biological, biospecimen and critical material experts, has announced the launch of a new sister company, Logical Antigen, focused on rapid and customised delivery of high-quality antigens and biologicals, for research and manufacturing.
Aenova, a global contract development and manufacturing organisation (CDMO), is expanding its site in Killorglin with a spray drying platform for amorphous solid dispersions (ASD) and inhalation powders.
Meech International has introduced the 906 Hyperion 24V Power Supply Unit (PSU), a compact, high-voltage AC power supply with 24VDC input developed to support static management equipment across a wide range of industrial settings.
As the UK’s transition away from F-gases ramps up, Aggreko has published a new report to provide clarity on the latest regulations and offer businesses guidance on the phase-down.
Ampersand Capital Partners, a private equity firm specialising in growth equity investments in the life sciences and healthcare sectors, has announced the acquisition of CurTec.
West Pharmaceutical Services, a specialist in innovative solutions for injectable drug administration, announced that it opened a new purpose-built analytical laboratory building near its manufacturing site in Stolberg.
The SciY business has announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into the SciY Laboratory Digitalization Suite.
One Biosciences has announced a €15 million Series A financing led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures, and Kima Ventures.
Arca BioLogistics, a specialist in Life Science logistics, has recently concluded on a development update of its logistics management portal Arca Live.
Xeltis has announced encouraging preliminary data for Xabg, its coronary artery bypass conduit (CABG), demonstrating positive safety and patency among patients with multi-vessel atherosclerotic coronary artery disease.
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, has announced the first results from a collaboration with Insilico Medicine.
